-
Mashup Score: 0Lung cancer rates for younger, middle-aged women higher than men's - 7 month(s) ago
GMA is your source for useful news and inspiration on how to live your best life. Your community and guide to relationship advice, the latest in celebrity news, culture, style, travel, home, finances, shopping deals, career and more.
Source: www.goodmorningamerica.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 4How to Bring Basic Science Discoveries to the Clinic | EACR-AACR-IACR Basic and Translational Research Conference - 7 month(s) ago
The European Association for Cancer Research (EACR) and American Association for Cancer Research (AACR) are proud to continue their Basic and Translational Research Conference series with this new joint conference in Dublin, Ireland in collaboration with the Irish Association for Cancer Research (IACR). Gathering top experts in the fields of immunology, drug development, tumour microenvironment, genomics and epigenetics, this Joint Conference will focus on bringing the latest discoveries from basic
Source: www.eai2024.orgCategories: Latest Headlines, Oncologists1Tweet-
Join us in Ireland! Abstract submission deadline tomorrow 10-16-23. Great group of faculty in a beautiful location! Full program here: https://t.co/zHRjWNOC9b @AACR @EACRnews @DrJNaidoo https://t.co/RTrJFfqrsV
-
-
Mashup Score: 2Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements - 7 month(s) ago
Zenocutuzumab, a HER2xHER3 bispecific antibody, reduces cell growth in NRG1-rearranged cancer cell lines and xenografts and induces durable clinical responses in patients with NRG1 fusion–positive tumors.
Source: aacrjournals.orgCategories: Latest Headlines, Oncologists1Tweet-
➡️ Zenocutuzumab (aka Zeno) This is a great #PrecisionMedicine story! ➡️ HER2xHER3 bispecific Ab ➡️ “Dock and Block” MOA ➡️ Tested in pan cancer with rare NRG1 fusions @CD_AACR @MSKCancerCenter https://t.co/aagxAhuZnD
-
-
Mashup Score: 1Renal Cancer Subtypes: Should We Be Lumping or Splitting for Therapeutic Decision Making? - 7 month(s) ago
The treatment of advanced renal cell carcinoma has posed a challenge for decades, in part because of common themes related to intrinsic resistance to cytotoxic chemotherapy, and the obscure biology of these cancer types. Forward movement in the treatment …
Source: www.ncbi.nlm.nih.govCategories: Latest Headlines, Oncologists1Tweet-
Starting a great day of learning @VUMC_Cancer with the @DrScottHaake teaching us about #kidneycancer. To learn more, check out Dr. Haake's review article here: https://t.co/0ygZTUm9aB And look out for great work coming from Dr. Haake's lab! @VUMC_Medicine https://t.co/reGjhmlj3G
-
-
Mashup Score: 2Directorships honor leaders, philanthropic partners - 7 month(s) ago
Nineteen leaders have been named as holders of directorships at Vanderbilt University Medical Center.
Source: news.vumc.orgCategories: Latest Headlines, Oncologists1Tweet-
Congrats the great @MaldonadoFabien for being named the inaugural Pierre Massion Director in #LungCancer research! What a fantastic memorial to our beloved departed colleague + friend, Pierre. @VUMChealth @LUNGevity https://t.co/ZyUylif2IQ
-
-
Mashup Score: 7Lectureship Award Winners Discuss Range of Issues in Thoracic Oncology During WCLC Plenary Session - ILCN.org (ILCN/WCLC) - 8 month(s) ago
Drs. Silvia Novello, Alan Sihoe, and D. Ross Camidge kicked off the session with forward-looking talks on tobacco control and smoking cessation, surgery, and medical oncology.
Source: www.ilcn.orgCategories: Latest Headlines, Oncologists1Tweet-
#lungcancer community - we know him + think the world of him! Congrats to Dr. Ross Camidge for being awarded the Daniel C. Ihde Lectureship at @IASLC #WCLC. "We should strive for perfect cancer control and quality of life for all" --> Aspirational! #LCSM https://t.co/uJNJsJMkBu https://t.co/SjzTGaKLmA
-
-
Mashup Score: 5Home - Rally for Medical Research - 8 month(s) ago
Join advocates from around the country for the 2023 Rally for Medical Research! The Hill Day will take place on Thursday, September 14, with advocates … Read moreHome
Source: rallyformedicalresearch.orgCategories: Latest Headlines, Oncologists1Tweet-
Research means hope! Today - Join the 11th Annual #RallyMedRes from anywhere in the USA by participating in the National Day of Action at https://t.co/cFa22FpOUB #CancerResearch #RallyMedRes #FundNIH @AACR @NIH @theNCI https://t.co/JsdcBrZRj3
-
-
Mashup Score: 14Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC - 8 month(s) ago
The programmed death-ligand 1 (PD-L1) immune checkpoint inhibitors, atezolizumab and durvalumab, have received regulatory approval for the first-line …
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists1Tweet-
Exciting initial results with alternative immune checkpoint proteins in heavily pre-treated #SCLC. In this case B7-H3 ADC. We also published pre-clinical data on B7-H6 in SCLC: https://t.co/PrCqSgTjIg #WCLC2023 #LCSM @OncoAlert https://t.co/lHrrNiAwBI
-
-
Mashup Score: 10
A combination of strict eligibility criteria and special requirements for insurance coverage mean that less than 6% of Americans at high risk gets screened for lung cancer.
Source: www.statnews.comCategories: Latest Headlines, Oncologists1Tweet-
#lungcancer screening rates are uniquely + unacceptably low! Great feature by @statnews. Please share. #LCSM @OncoAlert @IASLC @LUNGevity @AACR @GO2forLungCancr Why so few get screened for lung cancer, the deadliest cancer in the U.S. https://t.co/wB55UHoa4W via @statnews https://t.co/kwh7kB8iSo
-
-
Mashup Score: 0How to Bring Basic Science Discoveries to the Clinic | EACR-AACR-IACR Basic and Translational Research Conference - 9 month(s) ago
The European Association for Cancer Research (EACR) and American Association for Cancer Research (AACR) are proud to continue their Basic and Translational Research Conference series with this new joint conference in Dublin, Ireland in collaboration with the Irish Association for Cancer Research (IACR). Gathering top experts in the fields of immunology, drug development, tumour microenvironment, genomics and epigenetics, this Joint Conference will focus on bringing the latest discoveries from basic
Source: www.eai2024.orgCategories: Latest Headlines, Oncologists1Tweet-
https://t.co/zHRjWNOC9b 🔬Fantastic line up of international speakers. 💊 Topics: Immuno-Oncology, Cell Based Therapies, Novel Targets, Drug Combinations, Drug Resistance, Precancer Genome, #LiquidBiopsies, Preclinical Models, Tumor Microenvironment, Epigenetics. @AACR @EACRnews https://t.co/kgtaOOSiuQ https://t.co/lw1yyGDSRC
-
Join us in Dublin, Ireland Feb. 27-29, 2024 for this exciting joint international conference: "How to Bring Basic Science Discoveries to the Clinic" co-sponsored by @AACR @EACRnews + Irish Association for Cancer Research. 🧵/1 https://t.co/zHRjWNOC9b https://t.co/aU5MpBAbmQ
-
#Lungcancer rates are ⬆️ for women, including 🚺 <50: new study from @AmericanCancer. Thanks to @GMA for bringing much needed awareness to #lungcancer. @IASLC @LUNGevity @OncoAlert @lcfamerica @lcrf_org https://t.co/KtggpT8S7J